Survival Endpoints Validation
Survival Endpoints Validation is a methodological process in clinical and epidemiological research that assesses the accuracy, reliability, and clinical relevance of defined survival outcomes within a study to ensure they appropriately represent the underlying biological or disease progression phenomena.
90
Publications
5.5K
Citations
800
Authors
394
Institutions
Publications per year
2017–2026
44
Parents
90
William Morris, Scott Tyldesley, S. Rodda et al. · International Journal of Radiation Oncology*Biology*Physics · 2016 · 732 citations
Tomasz Burzykowski, Geert Molenberghs, Marc Buyse et al. · Journal of the Royal Statistical Society Series C (Applied Statistics) · 2001 · 218 citations · Full text
1–5 of 90
800
4
h-index
4
h-index
3
h-index
The University of Texas MD Anderson Cancer Center, United States
2 publications · 307 citations
3
h-index
3
h-index
1–5 of 800
394
Inserm
Paris, France
7 h-index
10 publications
484 citations
Mayo Clinic in Arizona
Scottsdale, United States
7 h-index
21 publications
372 citations
Memorial Sloan Kettering Cancer Center
New York, United States
6 h-index
14 publications
463 citations
National Cancer Institute
Bethesda, United States
5 h-index
8 publications
696 citations
Dana-Farber Cancer Institute
Boston, United States
4 h-index
18 publications
286 citations
Mayo Clinic
Rochester, United States
4 h-index
9 publications
692 citations
Harvard University
Cambridge, United States
4 h-index
13 publications
309 citations
International Drug Development Institute (Belgium)
Brussels, Belgium
4 h-index
5 publications
373 citations
1–8 of 394
4 publications · 831 citations
4
h-index
4 publications · 594 citations
4
h-index
4 publications · 280 citations
4
h-index
4 publications · 72 citations
4
h-index
3 publications · 337 citations
3
h-index
1–5